Eli Lilly Dividends and Buybacks
Dividend criteria checks 3/6
Eli Lilly is a dividend paying company with a current yield of 0.82% that is well covered by earnings. Next payment date is on 10th June, 2025 with an ex-dividend date of 16th May, 2025.
Key information
0.8%
Dividend yield
0.6%
Buyback Yield
| Total Shareholder Yield | 1.4% |
| Future Dividend Yield | 1.0% |
| Dividend Growth | 10.5% |
| Next dividend pay date | 10 Jun 25 |
| Ex dividend date | 16 May 25 |
| Dividend per share | n/a |
| Payout ratio | 44% |
Recent dividend and buyback updates
Eli Lilly (NYSE:LLY) Is Increasing Its Dividend To $1.50
Jan 15
Eli Lilly (NYSE:LLY) Will Pay A Larger Dividend Than Last Year At $1.50
Dec 28Eli Lilly (NYSE:LLY) Has Announced That It Will Be Increasing Its Dividend To $1.50
Dec 14Recent updates
Eli Lilly and Company Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next
May 05Eli Lilly: Why Orforglipron Matters, A Lot
Apr 28Eli Lilly: A New Leader In Weight Loss Drugs Is Clearly Emerging
Apr 20Eli Lilly: A Safe Harbor Amid Market Volatility
Mar 17We Think Eli Lilly's (NYSE:LLY) Profit Is Only A Baseline For What They Can Achieve
Feb 26Eli Lilly's Breakout Is Nearly Here: Performance Metrics/Bullish Support Remain Robust
Feb 23Eli Lilly Q4 Earnings: Now The Magical $1 Trillion Dollar Market Cap Is In Sight
Feb 06Eli Lilly and Company's (NYSE:LLY) Business Is Yet to Catch Up With Its Share Price
Feb 02Eli Lilly Stock's Correction Brings Opportunity
Jan 29Eli Lilly: Market Overreacted
Jan 21Eli Lilly (NYSE:LLY) Is Increasing Its Dividend To $1.50
Jan 15Eli Lilly: Still Much Room To Ride The Weight-Loss Wave
Jan 11Eli Lilly (NYSE:LLY) Will Pay A Larger Dividend Than Last Year At $1.50
Dec 28Eli Lilly: A Rare Buying Opportunity
Dec 17Eli Lilly (NYSE:LLY) Has Announced That It Will Be Increasing Its Dividend To $1.50
Dec 14Lilly's Head-To-Head Data Lands Blow On Novo In Battle For Weight Loss Supremacy
Dec 04Here's Why Eli Lilly (NYSE:LLY) Can Manage Its Debt Responsibly
Nov 29Eli Lilly: An Early Christmas Present Has Just Arrived (Rating Upgrade)
Nov 28Eli Lilly Stock: Unexpected Developments (Rating Downgrade)
Nov 21Eli Lilly and Company Just Missed EPS By 31%: Here's What Analysts Think Will Happen Next
Nov 01Taking A Look At Eli Lilly's Q3 2024 Revenue Miss Amid Supply Chain Challenges
Oct 30Upcoming Dividend Payment
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: LLY's dividends per share have been stable in the past 10 years.
Growing Dividend: LLY's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Eli Lilly Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (LLY) | 0.8% |
| Market Bottom 25% (US) | 1.6% |
| Market Top 25% (US) | 4.8% |
| Industry Average (Pharmaceuticals) | 2.8% |
| Analyst forecast (LLY) (up to 3 years) | 1.0% |
Notable Dividend: LLY's dividend (0.82%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.6%).
High Dividend: LLY's dividend (0.82%) is low compared to the top 25% of dividend payers in the US market (4.8%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (43.8%), LLY's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: LLY is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/11 19:20 |
| End of Day Share Price | 2025/05/09 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Eli Lilly and Company is covered by 57 analysts. 26 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Ishan Majumdar | Baptista Research |
| Luisa Hector | Berenberg |